You are here

Article Text

Article menu
Download PDFPDF
Letter
Neisseria gonorrhoeae confirmatory testing: helpful or a hindrance?
  1. Jonathan S Moore1,
  2. Nicole Gaukrodger2,
  3. Giuseppe Bignardi1
  1. 1 Microbiology Department, City Hospitals Sunderland NHS Foundation Trust, Sunderland, UK
  2. 2 Microbiology Department, South of Tyne Pathology Laboratories, Queen Elizabeth Hospital NHS Foundation Trust, Gateshead, UK
  1. Correspondence to Dr Jonathan S Moore, Microbiology Department, City Hospitals Sunderland NHS Foundation Trust, Kayll Road, Sunderland SR4 7TP, UK; Jonathan.Moore2{at}nhs.net

https://doi.org/10.1136/sextrans-2014-051802

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the paper by Perry et al 1 as we have just reviewed the performance of our own Neisseria gonorrhoea confirmatory testing strategy. We confirm extragenital samples positive for N. gonorrhoeae on the Cobas 4800NG using the CE-marked Duplicα real-time 2nd generation detection kit (Euroclone diagnostics).

    Of 76 pharyngeal samples testing positive on the Cobas 4800NG, only 25 (33%) confirmed on the Duplicα platform. However, 26/51 (51%) patients with unconfirmed …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.